ClinicalTrials.Veeva

Menu

Evaluation of Novel Noise Reduction Principles in Hearing Instruments

Sonova logo

Sonova

Status

Completed

Conditions

Hearing Loss

Treatments

Device: Measure of Noise Reduction Principle NR3
Device: Measures of Noise Reduction Principle NR2
Device: Measures of Standard Noise Reduction NR1

Study type

Interventional

Funder types

Industry

Identifiers

NCT05582408
SRF-382

Details and patient eligibility

About

In the study, the speech intelligibility in noise (Outcome) between a novel noise reduction algorithm (Intervention) versus the standard noise reduction (Comparator) will be tested in adults with a N3-N4 hearing loss (Population) using streamed signals via hearing aids.

Enrollment

26 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Minimum age for men: 18 years, minimum age for wom-en: 64 years, hearing aid users,
  • Written and spoken German,
  • Hearing loss range: N3-N4 Hearing loss (sensorineural)
  • Healthy outer ear,
  • Ability to understand and follow the instruction of the in-vestigator
  • Informed consent as documented by signature.

Exclusion criteria

  • Clinical contraindications 1) hearing loss is not within the fitting range of the hearing aid, 2) acute tinnitus, 3) de-formity of the ear (closed ear canal or absence of pinna), and 4) neural hearing loss i.e., retro-cochlear pathologies such as absent / non-viable auditory nerve
  • Pregnant or breastfeeding women
  • Age >85 years
  • known hypersensitivity or allergy,
  • limited mobility and not able to attend the appointments

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

26 participants in 2 patient groups

Hearing Aid Standard NR1
Active Comparator group
Description:
Hearing Aid with standard Noise Reduction (NR1) serves as reference condition.
Treatment:
Device: Measures of Standard Noise Reduction NR1
Novel Noise reduction principles
Experimental group
Description:
Noise Reduction Principle NR2 and NR3.
Treatment:
Device: Measures of Noise Reduction Principle NR2
Device: Measure of Noise Reduction Principle NR3

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems